Abstract:Purpose: We sought to identify a pathogenic mutation in an extended early onset osteoarthritis (OA) family. The value of such causal mutations lies in the functional characterization of the underlying biological mechanisms driving OA which, via extrapolation, can also give insight into common OA pathogenesis. Methods: Exome sequencing was applied to a relevant affected member of an extended family with early-onset primary OA without syndromic features. A prioritization scheme to identify the pathogenic mutation was applied, followed by de novo genotyping and linkage analysis across the family. Conformational changes in the protein were predicated by the online tool RaptorX (www.uchicago.raptorx.edu). To investigate the gene in common OA pathophysiology, expression analysis was performed in preserved and osteoarthritic cartilage of 33 independent patients undergoing joint replacement surgery (RAAK study). Results: Exome sequencing a relevant affected individual of the early-onset OA family resulted in the identification of a high impact, likely damaging, missense mutation in FN1, encoding fibronectin. De novo genotyping and linkage analysis confirmed that the FN1 mutation was carried in affected but not in un-affected family members (LOD score > 3), thereby being likely causal to the early onset of OA in this family. The identified mutation is located in the gelatin-binding domain and structure prediction indicated a significant change in the conformation of the protein. Gene expression analysis in preserved and affected cartilage in OA patients showed that the FN1 gene was among the highest upregulated in OA lesioned tissue compared to preserved tissue (2.3-fold, P-value = 1.13x10-5). Conclusions: We have demonstrated that a high impact mutation in FN1 is likely causal to OA in an extended family, thereby confirming that proper cellular function of fibronectin is crucial to maintain articular cartilage tissue homeostasis, whereas aberrant function of fibronectin potentially modulates underlying pathophysiology of OA. Due to their strong effect, high impact mutations can provide direct clues to underlying disease mechanisms as they are actionable to express a particular disease state in experimental in vitro models. Since the underlying pathway in which fibronectin is functioning is likely extrapolated to confer risk to common OA, the identified mutation provides a unique opportunity to dissect underlying mechanisms of the FN1 pathway in OA in the general population.

The role of TNFRSF11B in development of osteoarthritic cartilage

A Gain of Function Mutation in TNFRSF11B Causes Osteoarthritis with Chondrocalcinosis

A gain of function mutation in TNFRSF11B encoding osteoprotegerin causes osteoarthritis with chondrocalcinosis

The pro-inflammatory effect of NR4A3 in osteoarthritis

Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study

A Damaging COL6A3 Variant Alters the MIR31HG‐Regulated Response of Chondrocytes in Neocartilage Organoids to Hyperphysiologic Mechanical Loading

IDENTIFICATION OF A HIGH IMPACT MUTATION IN THE FN1 GENE IN EARLY-ONSET OSTEOARTHRITIS FAMILY

Genetic and Epigenetic Fine‐Tuning of TGFB1 Expression Within the Human Osteoarthritic Joint

ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway

PR11‐364P22.2/ATF3 Protein Interaction Mediates IL‐1β‐induced Catabolic Effects in Cartilage Tissue and Chondrocytes

Comprehensive profiling of transcriptional regulation in cartilage reveals pathogenesis of osteoarthritis

Inhibition of Nuclear Receptor RORα Attenuates Cartilage Damage in Osteoarthritis by Modulating IL-6/STAT3 Pathway

Deletion of the Transforming Growth Factor Β Receptor Type II Gene in Articular Chondrocytes Leads to a Progressive Osteoarthritis-Like Phenotype in Mice.

Role of Nuclear Factor of Activated T Cells 1 in the Pathogenesis of Osteoarthritis.

Targeted inhibition of TXNRD1 prevents cartilage extracellular matrix degeneration by activating Nrf2 pathway in osteoarthritis

RNA sequencing uncovers key players of cartilage calcification: potential implications for osteoarthritis pathogenesis

Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis

Influence of osteoarthritis grade on molecular signature of human cartilage

S100B Regulates Inflammatory Response During Osteoarthritis Via Fibroblast Growth Factor Receptor 1 Signaling.

Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints

Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis